2018 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 49 |
Best rating | 577 % |
Worst rating | -671 % |
New companies | 6 |
Negative Economic Capital Ratio | 19 of 49 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 49 |
Best rating | 577 % |
Worst rating | -671 % |
New companies | 6 |
Negative Economic Capital Ratio | 19 of 49 |
Navidea Biopharmaceuticals Inc. climbed 36 positions from 37 to 1 due to its excellent Net Income.FITLIFE BRANDS INC. lost 26 positions from 14 to 40 due to its bad Expenses.MARIMED INC. entered the 2018 ranking at rank 20, making it the best newcomer.
Revenues | 28.2 B |
Assets | 45.6 B |
Expenses | 27.1 B |
Stockholders Equity | 18.5 B |
Unprofitable Companies | 28 of 49 |
We’re thrilled to have participated in the TDWI [https://www.linkedin.com/company/tdwi/] Roundtable held on April [...]
Photo source: https://openai.com/dall-e-3/ RealRate is excited to announce that the new 2024 [...]
We are extremely excited to announce that an interview with Holger Bartel has [...]
On February 14th, 2024, something momentous happened. Nvidia, the chip and graphics card [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Pharma are [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Savings are [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Chemicals are [...]
Source: https://openai.com/dall-e-3/ The machines have emerged and the results for RealRate’s 2023 [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai